| Margaret J Neff, | |
|
3801 Miranda Ave Bldg 100-f3, Palo Alto, CA 94304-1207 | |
| (650) 493-5000 | |
| Not Available |
| Full Name | Margaret J Neff |
|---|---|
| Gender | Female |
| Speciality | Internal Medicine - Critical Care Medicine |
| Location | 3801 Miranda Ave Bldg 100-f3, Palo Alto, California |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1356427157 | NPI | - | NPPES |
| 8263741 | Medicaid | WA | |
| 225390 | Other | INTERNAL ID-MOTOR VEHICLE ID |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RC0200X | Internal Medicine - Critical Care Medicine | G80330 (California) | Primary |
| 207RP1001X | Internal Medicine - Pulmonary Disease | G80330 (California) | Secondary |
| Mailing Address | Practice Location Address |
|---|---|
| Margaret J Neff, 3801 Miranda Ave Bldg 100-f3, Palo Alto, CA 94304-1207 Ph: (650) 493-5000 | Margaret J Neff, 3801 Miranda Ave Bldg 100-f3, Palo Alto, CA 94304-1207 Ph: (650) 493-5000 |
News Archive
Arena Pharmaceuticals, Inc. and Eisai Inc. announced today the completion of an end-of-review meeting with the US Food and Drug Administration (FDA) for the lorcaserin New Drug Application (NDA).
As part of his doctoral research at The Norwegian School of Veterinary Science, Demelash Biffa has carried out extensive field and laboratory work on bovine tuberculosis (TB) in Ethiopia since 2007. The main aims of his study were to investigate risk factors associated with prevalence of the disease and to discover the molecular genetic characteristics of mycobacteria, which cause serious pathologic lesions in cattle. The work has led to the development of a new numeric expression approach known as Spoligotype Evolutionary Index (SEI).
The Illinois Legislature this week voted unanimously to override Gov. Rod Blagojevich's (D) revisions of a bill to give uninsured Illinois residents a discount on hospital care, the Chicago Tribune's "Triage" reports.
OraSure Technologies, Inc., the market leader in oral fluid diagnostics, today announced that the U.S. Food and Drug Administration ("FDA") has granted an investigational device exemption (IDE) for the Company to conduct the final phase of clinical testing for FDA approval of its OraQuick® Rapid HIV-1/2 Antibody Test for sale in the consumer or over-the-counter ("OTC") market.
› Verified 4 days ago
Daniel Joseph Razzano, M.D. Critical Care Medicine Medicare: Medicare Enrolled Practice Location: 3801 Miranda Ave, Palo Alto, CA 94304 Phone: 650-493-5000 | |
Mahnoosh Kuhbanani Seifoddini, M.D. Critical Care Medicine Medicare: Medicare Enrolled Practice Location: 3801 Miranda Ave, Va Palo Alto Health Care System (111stc), Palo Alto, CA 94304 Phone: 209-946-3400 | |
Dr. Yusra Nazar Hussain, M.D. Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 770 Welch Rd, Suite # 250, Palo Alto, CA 94304 Phone: 650-328-1676 Fax: 650-445-0911 | |
Dr. David Yao, M.D. Critical Care Medicine Medicare: Medicare Enrolled Practice Location: 3801 Miranda Ave, Medical Services (111a), Palo Alto, CA 94304 Phone: 650-493-5000 | |
Dr. Franklin Perry, M.D. Critical Care Medicine Medicare: Not Enrolled in Medicare Practice Location: 2175 Park Blvd, Palo Alto, CA 94306 Phone: 650-330-3688 Fax: 650-330-3686 | |
Dr. Ryan Arthur Mcconnell, MD Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 795 El Camino Real, Palo Alto, CA 94301 Phone: 650-853-2972 | |
Dr. Ann Margaretha Lowe, M.D. Critical Care Medicine Medicare: Not Enrolled in Medicare Practice Location: 420 Cambridge Ave, Unit 3, Palo Alto, CA 94306 Phone: 650-323-6614 |